Financial reports
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
ARS
2022 FY
Annual report to shareholders
19 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
14 Mar 24
8-K
Protalix BioTherapeutics Issues 2024 Letter to Stockholders
26 Dec 23
8-K
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results
6 Nov 23
8-K
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
12 Sep 23
8-K
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results
7 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
13 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
29 Jun 23
8-K
Protalix BioTherapeutics Issues Letter to Stockholders
30 May 23
8-K
Results of Operations and Financial Condition
18 May 23
8-K
Other Events
10 May 23
Registration and prospectus
S-8
Registration of securities for employees
11 Aug 23
424B3
Prospectus supplement
7 Jul 23
424B5
Prospectus supplement for primary offering
27 Feb 23
S-8
Registration of securities for employees
14 Jul 22
424B5
Prospectus supplement for primary offering
2 May 22
S-3
Shelf registration
20 Apr 22
424B5
Prospectus supplement for primary offering
2 Jul 21
424B5
Prospectus supplement for primary offering
2 Jul 21
424B5
Prospectus supplement for primary offering
16 Feb 21
424B5
Prospectus supplement for primary offering
11 Feb 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Jun 23
DEF 14A
Definitive proxy
18 May 23
PRE 14A
Preliminary proxy
2 May 23
DEFA14A
Additional proxy soliciting materials
16 Jun 22
DEF 14A
Definitive proxy
29 Apr 22
PRE 14A
Preliminary proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
9 Nov 21
DEF 14A
Definitive proxy
30 Sep 21
PRE 14A
Preliminary proxy
17 Sep 21
DEF 14A
Definitive proxy
4 Jun 21
Other
UPLOAD
Letter from SEC
30 Jun 22
CORRESP
Correspondence with SEC
29 Jun 22
UPLOAD
Letter from SEC
23 Jun 22
EFFECT
Notice of effectiveness
2 May 22
CORRESP
Correspondence with SEC
27 Apr 22
UPLOAD
Letter from SEC
25 Apr 22
EFFECT
Notice of effectiveness
30 Apr 20
CORRESP
Correspondence with SEC
27 Apr 20
UPLOAD
Letter from SEC
22 Apr 20
CT ORDER
Confidential treatment order
17 Dec 19